The opioid epidemic is helping reduce prescriptions for opioid-based pharmacotherapy. However, parallel to this drop has been an increase in gabapentin and pregabalin prescriptions.  Why has this occurred and what should the clinician know about this phenomenon?Additional Resources/References: Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016. Zhou L, Bhattacharjee S, Kwoh CK, Tighe PJ, Malone DC, Slack M, Wilson DL, Brown JD, Lo-Ciganic WH. J Clin Med. 2019 Dec 29;9(1):83. doi:10.3390/jcm9010083.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

Follow CEimpact on Social Media:
LinkedIn
Instagram